Company: HCWB
Filing Date: 2025-08-18
Form Type: 10-Q
Source: 0000950170-25-109642
Chunk: 12

Company: HCW Biologics Inc.
Filing Date: 2025-08-18
Form: 10-Q
Item: Item 1
Chunk 12
---
HCW Biologics Inc. 

Condensed Balance Sheets 

     December 31,

     June 30,

     2024

     2025

     Unaudited

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     4,674,572

     $
     2,438,962

     Accounts receivable, net

     582,201

     21,611

     Prepaid expenses

     328,181

     295,543

     Other current assets

     113,528

     141,009

     Total current assets

     5,698,482

     2,897,125

     Investments

     1,599,751

     3,348,438

     Property, plant and equipment, net

     22,909,869

     22,635,596

     Other assets

     28,476

     28,477

     Total assets
      
     $
     30,236,578

     $
     28,909,636

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Liabilities

     Current liabilities:

     Accounts payable
      
     $
     22,332,261

     $
     19,354,476

     Accrued liabilities and other current liabilities

     981,940

     1,070,421

     Short-term debt, net

     6,314,684

     6,421,204

     Total current liabilities

     29,628,885

     26,846,101

     Debt, net

     7,377,865

     367,151

     Contingent liability - related party

     —

     1,748,356

     Total liabilities

     37,006,750

     28,961,608

     Commitments and contingencies (Note 11)

     Stockholders’ deficit:

     Common stock:

     Common, $0.0001 par value; 250,000,000 shares authorized   and 1,113,532 shares issued at December 31, 2024; 250,000,000 shares    authorized and 2,146,601 shares issued at June 30, 2025

     111

     215

     Additional